Resting-state dynamics as a neuromarker of dopamine administration in healthy female adults.

These results demonstrate that modulations of resting-state brain dynamics induced by a DA agonist predict drug-related effects on evaluation processes, providing a neuromarker of the neural responsiveness of specific brain networks to DA administration.